Boston Scientific (BSX) analyst forecast and price target
Analyst forecast
Consensus of 33 analyst ratings
Based on 14 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| TD Cowen | Maintained | Buy | $56.00 | Aug 25, 2026 |
| Argus Research | Downgraded | Buy → Hold | — | Jul 31, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $50.00 from $55.00 | Jul 30, 2026 |
| Evercore ISI Group | Maintained | Outperform | $55.00 from $65.00 | Jul 30, 2026 |
| Truist Securities | Maintained | Buy | $57.00 from $62.00 | Jul 30, 2026 |
| Canaccord Genuity | Maintained | Buy | $66.00 from $70.00 | Jul 30, 2026 |
| TD Cowen | Maintained | Buy | $56.00 from $61.00 | Jul 30, 2026 |
| RBC Capital | Maintained | Outperform | $70.00 from $85.00 | Jul 30, 2026 |
| Citigroup | Maintained | Buy | $61.00 from $70.00 | Jul 30, 2026 |
| UBS | Maintained | Buy | $67.00 from $74.00 | Jul 30, 2026 |
| BTIG | Maintained | Buy | $60.00 from $65.00 | Jul 29, 2026 |
| UBS | Initiated Coverage | Buy | $74.00 from $95.00 | Jul 28, 2026 |
| Oppenheimer | Maintained | Outperform | $85.00 from $90.00 | Jul 27, 2026 |
| Truist Securities | Maintained | Buy | $62.00 from $64.00 | Jul 16, 2026 |
| Mizuho | Maintained | Outperform | $70.00 from $90.00 | Jul 15, 2026 |
| RBC Capital | Maintained | Outperform | $85.00 from $100.00 | Jul 13, 2026 |
| Needham | Maintained | Buy | $57.00 from $77.00 | Jul 8, 2026 |
| Evercore ISI Group | Maintained | Outperform | $65.00 from $78.00 | Jul 6, 2026 |
| Stifel | Maintained | Buy | $65.00 from $75.00 | Jun 25, 2026 |
| Jefferies | Maintained | Buy | $67.00 from $100.00 | Jun 24, 2026 |
Frequently asked questions
What is the price target for BSX stock?
The average 12-month analyst price target for Boston Scientific (BSX) is $63.29, with a high estimate of $85.00 and a low of $50.00, across 14 analysts.
Is BSX a buy, sell, or hold?
Analysts covering Boston Scientific currently average a Buy rating: 28 buy, 5 hold and 0 sell, from 33 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for BSX?
The average price target of $63.29 implies 31.03% upside from the last price of $48.30.
What is the latest analyst rating on BSX?
On Aug 25, 2026, TD Cowen maintained Boston Scientific at Buy with a price target of $56.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.